http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-597916-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd0f4a0cdae6bcb4f8937d57380722dd |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D455-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D455-03 |
filingDate | 2010-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_784d5f9df3baa217e0e6a951d51f20b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87e4a098e2c9745c7ee0189488c09eab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cd407b7886e46f3f7b6b405acbf2bda |
publicationDate | 2013-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | NZ-597916-A |
titleOfInvention | Benzoquinolizinium salt derivatives as anticancer agents |
abstract | Disclosed are 13-substituted 5,6-dihydrodibenzo[a,g]quinolizinium salt compounds according to Formula (I) and methods for their preparation. Specific examples of compounds of Formula (I) include: 13-[2-(phenyl)ethyl]-9,10-dimethoxy-5,6-dihydrobenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium iodide, 13-[2-(naphth-1-yl)ethyl]-9,10-dimethoxy-5,6-dihydrobenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium iodide, 13-[3-(4-chlorophenyl)propyl]-9,10-dimethoxy-5,6-dihydrobenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium iodide, and 13-[(4-pyridyl)carbonylaminomethyl]-9,10-dimethoxy-5,6-dihydrobenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium iodide. Compounds of formula (I) are in the class of protoberberines and are useful for treating cancer. |
priorityDate | 2009-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.